<code id='4FE90D8FDF'></code><style id='4FE90D8FDF'></style>
    • <acronym id='4FE90D8FDF'></acronym>
      <center id='4FE90D8FDF'><center id='4FE90D8FDF'><tfoot id='4FE90D8FDF'></tfoot></center><abbr id='4FE90D8FDF'><dir id='4FE90D8FDF'><tfoot id='4FE90D8FDF'></tfoot><noframes id='4FE90D8FDF'>

    • <optgroup id='4FE90D8FDF'><strike id='4FE90D8FDF'><sup id='4FE90D8FDF'></sup></strike><code id='4FE90D8FDF'></code></optgroup>
        1. <b id='4FE90D8FDF'><label id='4FE90D8FDF'><select id='4FE90D8FDF'><dt id='4FE90D8FDF'><span id='4FE90D8FDF'></span></dt></select></label></b><u id='4FE90D8FDF'></u>
          <i id='4FE90D8FDF'><strike id='4FE90D8FDF'><tt id='4FE90D8FDF'><pre id='4FE90D8FDF'></pre></tt></strike></i>

          hotspot

          hotspot

          author:comprehensive    Page View:531
          Photograph of an abandoned lab with empty bottle, boxes, and beakers all around. -- biotech coverage from STAT
          Adobe

          SAN DIEGO — It was spring 2020, and Histogen, a small biotech with big ambitions to regenerate tissues throughout the body and turn a profit in the process, had just gone public. The company’s leadership believed they were poised for success — until everything slowly and irreversibly fell apart.

          Three years later, Histogen no longer develops therapies. It has abandoned efforts to reverse baldness, replenish cartilage in achy knees, and quell infection and inflammation.

          advertisement

          The company has no lab. It has no headquarters. It has just two employees, including a chief financial officer who also serves as secretary, CEO, and president. Histogen’s stock trades below $1 a share. And even that is coming to a close. On Thursday, the Nasdaq suspended trading of Histogen shares after determining that the company’s operations and assets are negligible, meaning the biotech is now officially a shell of its former self.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          knowledge

          Jerome Adams on the need for new antivirals for Covid
          Jerome Adams on the need for new antivirals for Covid

          PaxlovidtabletsamplesbeinginspectedinFreiburg,Germany.PfizerviaAPTheU.S.Covid-19Public HealthEmergen

          read more
          It was time to plan for my old age. If only I could stop crying
          It was time to plan for my old age. If only I could stop crying

          MikeReddyforSTATAtwo-dayexcursiontoNewHampshire,atthepeakoffallfoliageseason,shouldbeatreat.Sohowcom

          read more
          Activists slam private health insurers over coverage restrictions
          Activists slam private health insurers over coverage restrictions

          ProtestorsoutsideAmerica'sHealthInsurancePlansheadquarters.CourtesyPeople'sActionWASHINGTON—Hun

          read more

          Pennsylvania man bitten on the head by bear during attack in his garage

          DANVILLE,Pa.--APennsylvaniamansayshe'spayingalotmoreattentiontohissurroundingsafterasurpriseatt